387 related articles for article (PubMed ID: 23687223)
1. Plasma viral microRNA profiles reveal potential biomarkers for chronic active Epstein-Barr virus infection.
Kawano Y; Iwata S; Kawada J; Gotoh K; Suzuki M; Torii Y; Kojima S; Kimura H; Ito Y
J Infect Dis; 2013 Sep; 208(5):771-9. PubMed ID: 23687223
[TBL] [Abstract][Full Text] [Related]
2. Circulating Epstein-Barr virus-encoded micro-RNAs as potential biomarkers for nasal natural killer/T-cell lymphoma.
Komabayashi Y; Kishibe K; Nagato T; Ueda S; Takahara M; Harabuchi Y
Hematol Oncol; 2017 Dec; 35(4):655-663. PubMed ID: 27709652
[TBL] [Abstract][Full Text] [Related]
3. Plasma EBV microRNAs in paediatric renal transplant recipients.
Hassan J; Dean J; De Gascun CF; Riordan M; Sweeney C; Connell J; Awan A
J Nephrol; 2018 Jun; 31(3):445-451. PubMed ID: 29185211
[TBL] [Abstract][Full Text] [Related]
4. EBV-encoded microRNAs profile evaluation in pediatric liver transplant recipients.
Bergallo M; Gambarino S; Pinon M; Barat V; Montanari P; Daprà V; Galliano I; Calvo PL
J Clin Virol; 2017 Jun; 91():36-41. PubMed ID: 28414949
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus mir-bart1-5p detection via nasopharyngeal brush sampling is effective for diagnosing nasopharyngeal carcinoma.
Zheng XH; Lu LX; Cui C; Chen MY; Li XZ; Jia WH
Oncotarget; 2016 Jan; 7(4):4972-80. PubMed ID: 26701721
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of Epstein-Barr virus (EBV)-related gene expression in patients with chronic active EBV infection.
Iwata S; Wada K; Tobita S; Gotoh K; Ito Y; Demachi-Okamura A; Shimizu N; Nishiyama Y; Kimura H
J Gen Virol; 2010 Jan; 91(Pt 1):42-50. PubMed ID: 19793909
[TBL] [Abstract][Full Text] [Related]
7. Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs.
Wong AM; Kong KL; Tsang JW; Kwong DL; Guan XY
Cancer; 2012 Feb; 118(3):698-710. PubMed ID: 21720996
[TBL] [Abstract][Full Text] [Related]
8. Detection of Epstein-Barr virus (EBV)-encoded microRNAs in plasma of patients with nasopharyngeal carcinoma.
Gao W; Wong TS; Lv KX; Zhang MJ; Tsang RK; Chan JY
Head Neck; 2019 Mar; 41(3):780-792. PubMed ID: 30548946
[TBL] [Abstract][Full Text] [Related]
9. Dynamic expression of viral and cellular microRNAs in infectious mononucleosis caused by primary Epstein-Barr virus infection in children.
Gao L; Ai J; Xie Z; Zhou C; Liu C; Zhang H; Shen K
Virol J; 2015 Dec; 12():208. PubMed ID: 26634702
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic values for the viral load in peripheral blood mononuclear cells of patients with chronic active Epstein-Barr virus disease.
Ito Y; Suzuki M; Kawada J; Kimura H
J Infect Chemother; 2016 Apr; 22(4):268-71. PubMed ID: 26712582
[TBL] [Abstract][Full Text] [Related]
11. Profiling of EBV-Encoded microRNAs in EBV-Associated Hemophagocytic Lymphohistiocytosis.
Zhou C; Xie Z; Gao L; Liu C; Ai J; Zhang L; Shen K
Tohoku J Exp Med; 2015 Oct; 237(2):117-26. PubMed ID: 26423217
[TBL] [Abstract][Full Text] [Related]
12. Dominant expression of interleukin-10 and transforming growth factor-beta genes in activated T-cells of chronic active Epstein-Barr virus infection.
Ohga S; Nomura A; Takada H; Tanaka T; Furuno K; Takahata Y; Kinukawa N; Fukushima N; Imai S; Hara T
J Med Virol; 2004 Nov; 74(3):449-58. PubMed ID: 15368517
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus microRNA miR-BART2-5p accelerates nasopharyngeal carcinoma metastasis by suppressing RNase Ⅲ endonuclease DICER1.
Wu Y; Zhang X; Liu C; Li Z; Wen Y; Zheng R; Xu C; Tian J; Wei L; Wang J; Yan Q; Zheng X; Ma J
J Biol Chem; 2023 Sep; 299(9):105082. PubMed ID: 37495108
[TBL] [Abstract][Full Text] [Related]
14. Clinical analysis and follow-up study of chronic active Epstein-Barr virus infection in 53 pediatric cases.
Lu G; Xie ZD; Zhao SY; Ye LJ; Wu RH; Liu CY; Yang S; Jin YK; Shen KL
Chin Med J (Engl); 2009 Feb; 122(3):262-6. PubMed ID: 19236801
[TBL] [Abstract][Full Text] [Related]
15. Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment.
Zhang G; Zong J; Lin S; Verhoeven RJ; Tong S; Chen Y; Ji M; Cheng W; Tsao SW; Lung M; Pan J; Chen H
Int J Cancer; 2015 Mar; 136(5):E301-12. PubMed ID: 25213622
[TBL] [Abstract][Full Text] [Related]
16. Profiling of Virus-Encoded MicroRNAs in Epstein-Barr Virus-Associated Gastric Carcinoma and Their Roles in Gastric Carcinogenesis.
Shinozaki-Ushiku A; Kunita A; Isogai M; Hibiya T; Ushiku T; Takada K; Fukayama M
J Virol; 2015 May; 89(10):5581-91. PubMed ID: 25740983
[TBL] [Abstract][Full Text] [Related]
17. Persistently high Epstein-Barr virus (EBV) loads in peripheral blood lymphocytes from patients with chronic active EBV infection.
Maeda A; Wakiguchi H; Yokoyama W; Hisakawa H; Tomoda T; Kurashige T
J Infect Dis; 1999 Apr; 179(4):1012-5. PubMed ID: 10068600
[TBL] [Abstract][Full Text] [Related]
18. Increased cell-free viral DNA in fatal cases of chronic active Epstein-Barr virus infection.
Kanegane H; Wakiguchi H; Kanegane C; Kurashige T; Miyawaki T; Tosato G
Clin Infect Dis; 1999 Apr; 28(4):906-9. PubMed ID: 10825059
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and laboratory characteristics of chronic active Epstein-Barr virus infection in children].
Mao JQ; Yang SL; Song H; Zhao FY; Xu XJ; Gu ME; Tang YM
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Nov; 16(11):1081-5. PubMed ID: 25406547
[TBL] [Abstract][Full Text] [Related]
20. Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection.
Bauer CC; Aberle SW; Popow-Kraupp T; Kapitan M; Hofmann H; Puchhammer-Stöckl E
J Med Virol; 2005 Jan; 75(1):54-8. PubMed ID: 15543583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
